Seed VC · USA

Atlas Ventures

Active

What they invest in

We build breakthrough biotechnology companies. We are partnering with the world's best life science entrepreneurs to translate groundbreaking science into life-changing medicines.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Enterprise

Geography

US, Europe

Recent investments

  • Kailera
  • Obsidian
  • Vima

The people who write checks

12 partners on file at Atlas Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Atlas Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Atlas Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Dec 2024
Portfolio last checked
Oct 6, 2026
Website
atlasventure.com ↗

Other firms investing in DeepTech

See all investors

Is Atlas Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Atlas Ventures is one of them, and we'll tell you exactly where they sit in your top 100.